Systems Oncology LLC, a privately held biopharmaceutical company developing a new class of multi-modal RNA therapeutics, announced today that the management team will be presenting and participating at the following upcoming conferences.
H.C. Wainwright 23rd Annual Global Investment Conference
Company Presentation
Presented by Dr. Spyro Mousses, CEO
September 10th, 2021, 3:00pm ET
Virtual
Wells Fargo 2021 Virtual Healthcare Conference
Fireside Chat
Presented by Dr. Spyro Mousses, CEO
September 10th, 2021, 4:00pm ET
Virtual
TIDES USA Conference
Arromer - Receptor Directed Delivery for Ultra-precise RNAi Multi-targeting
Presented by Dr. Spyro Mousses, CEO
September 23rd, 2021, 12:20pm ET
Boston, MA
Archived replays of the webcasts following each event will be available on Systems Oncology’s website at https://www.systemsoncology.com/news-and-events/
About Systems Oncology:
Systems Oncology is developing a new class of multimodal RNA therapeutics that simultaneously silence the right combination of disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. Our Arromer platform is used to digitally engineer and rapidly produce self-delivering therapeutics which are directed to specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of drug products in oncology, yet our multimodal RNA therapeutics platform can be harnessed to transform outcomes for any complex polygenic disease.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210907005083/en/
Contacts
Company & Investors:
Andrew Matricaria, CFO
andrew@systemsoncology.com
(312) 952-3451
Media:
Courtney Villani
CVillani@systemsoncology.com
(619) 807-1467
Source: Systems Oncology LLC
View this news release online at:
http://www.businesswire.com/news/home/20210907005083/en
